Company profile
Ekso Bionics
Ekso Bionics develops wearable robotic exoskeletons for rehabilitation and mobility assistance. Its technology helps patients and people with spinal cord i...
Facts
- Segment
- EXOSKELETON
- Country
- US
- Headquarters
- San Rafael
- Founded
- 2005
- Ticker
- EKSO
- Website
- https://eksobionics.com/
About Ekso Bionics
Ekso Bionics develops powered exoskeletons for rehabilitation, personal mobility and physical assistance. EksoNR supports clinician-guided gait training, while Ekso Indego products extend the portfolio into personal and home or community use.
The systems assist standing and walking for people with neurological or mobility impairments under product-specific programmes. Indications, clinical supervision, reimbursement and availability vary by model, user eligibility and jurisdiction.
Market context
DEPLOYMENT
Summary
Type: Exoskeletons
Core: EksoNR
Function: Gait rehab
Audience: Healthcare
Research, Articles and recent verified events
- Ekso Bionics prices $5.852 million private placement — 2026-01-21
- Ekso Bionics inks agreement to become the exclusive U.S. distributor of MediTouch BalanceTutor — 2025-12-04
- Ekso Bionics announces $3.7 million registered direct offering — 2025-10-29
- Ekso Bionics demonstrates early AI voice-agent proof of concept following NVIDIA Connect acceptance — 2025-06-18
- Ekso Bionics accepted into NVIDIA Connect program for rehabilitation AI initiative — 2025-05-15
- Bionic P&O chosen as first distributor of Ekso Indego Personal in the U.S. orthotics and prosthetics market — 2025-04-23
- Ekso Bionics names National Seating & Mobility exclusive U.S. CRT distributor for Ekso Indego Personal — 2025-03-18
- EksoNR receives FDA clearance for acquired brain injury rehabilitation — 2020-06-15